‘Human-in-the-loop’ approach could cut costs of robotic labs by 90%news2026-04-20T13:45:00+00:00April 20th, 2026|Chemistry World|
Lilly to buy Kelonia for $3.25B upfront, underlining its in vivo CAR-T strategynews2026-04-20T13:25:03+00:00April 20th, 2026|Endpoints News|
Nektar’s long-term mid-stage alopecia data fuel Phase 3 plansnews2026-04-20T11:32:12+00:00April 20th, 2026|Endpoints News|
Novo Nordisk’s sickle cell therapy hits in Phase 3, but data lag expectationsnews2026-04-20T10:46:34+00:00April 20th, 2026|Endpoints News|
